ADCs are currently at the forefront of cancer treatment, but persistent drug development challenges call for a new approach.

Mark Erlander; Chief Executive Officer, Director; Cardiff Oncology Inc. James Levine; Chief Financial Officer; Cardi ...

The European Union's health regulator on Friday backed AstraZeneca and Daiichi Sankyo's drug Enhertu as a breast cancer ...

Puma Biotechnology Inc (PBYI) reports strong revenue growth and strategic distribution expansions, despite facing challenges in royalty revenue and new patient acquisition.

The hockey rivalry between the United States and Canada is one of the premier sports conflicts of all time. It’s a rivalry that is so heated that both the men’s and women’s games have their ...

The 4 Nations Face-Off final is set. A 5-3 win for Canada in Monday's game against Finland has pushed it through to the championship game, where it will face the United States. The U.S. clinched ...

Editor's note: Follow USA vs. Canada live updates from the 4 Nations Face-Off hockey final. The USA and Canada will play for the championship of the 4 Nations Face-Off on Thursday night in Boston.

It took a while for Canadian politicians to figure out that Donald Trump wasn't joking with his talk about annexing Canada. After Trump raised the idea at a dinner in Mar-A-Lago attended by Prime ...

This list highlights the best universities in Canada based on the trusted Times Higher Education World University Rankings 2025. Our comprehensive evaluation covers key areas such as teaching quality, ...

Enhertu is approved for HR-positive, HER2-low or -ultralow metastatic breast cancer, expanding treatment options for these patients. DESTINY-Breast06 trial showed Enhertu reduced disease progression ...

Tariffs would need to be in place for years to alter US-Canada crude flows, Enbridge says Tariffs on Canadian oil would need to be in place for years before significantly altering the amount of ...

Among the newly launched brands, the gastro segment recorded the highest sales at Rs 167 crore from 394 brands. The anti-neoplast/immunomodulator category, used in ...